Wolfgang H. Jost

Best Publications

• Leitlinien für Diagnostik und Therapie in der Neurologie

  H. C. Diener;C. Weimar;P. Berlit;G. Deuschl

  485
  Citations

• Vulnerability of the nigrostriatal system as detected by transcranial ultrasound

  D. Berg;G. Becker;B. Zeiler;O. Tucha

  430
  Citations

• Nonmotor fluctuations in Parkinson disease: Severity and correlation with motor complications.

  Alexander Storch;Christine B Schneider;Martin Wolz;Yannic Stürwald

  388
  Citations

• Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm

  Unknown

  243
  Citations

• High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study

  M. Graf;D. Ecker;R. Horowski;B. Kramer

  237
  Citations

• Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.

  Anthony H. V. Schapira;Susan H. Fox;Robert A. Hauser;Joseph Jankovic

  226
  Citations

• Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease.

  J. Spiegel;D. Hellwig;S. Samnick;W. Jost

  193
  Citations

• Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease

  Jörg Spiegel;Dirk Hellwig;Marc-Oliver Möllers;Stefanie Behnke

  166
  Citations

• Botulinum toxin: Clinical use

  Daniel D. Truong;Wolfgang H. Jost

  153
  Citations

• Botulinum Neurotoxin Type A Free of Complexing Proteins (XEOMIN??) in Focal Dystonia

  Unknown

  135
  Citations

• Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy

  Wolfgang H. Jost;Harald Hefter;Andrea Stenner;Gerhard Reichel

  127
  Citations

• Classification of posture in poststroke upper limb spasticity: a potential decision tool for botulinum toxin A treatment?

  Harald Hefter;Wolfgang H. Jost;Andrea Reissig;Benjamin Zakine

  125
  Citations

• Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease.

  Jörg Spiegel;Dirk Hellwig;Georgios Farmakis;Wolfgang H. Jost

  122
  Citations

• SIAXI

  Unknown

  113
  Citations

• FP‐CIT and MIBG scintigraphy in early Parkinson's disease

  Unknown

  113
  Citations

• α-Synuclein in Parkinson's disease: causal or bystander?

  Peter Riederer;Peter Riederer;Daniela Berg;Nicolas Casadei;Fubo Cheng

  107
  Citations

• Management of Pain in Parkinson's Disease

  Carsten Buhmann;Jan Kassubek;Wolfgang H Jost

  91
  Citations

• Quantitative assessment of non-motor fluctuations in Parkinson’s disease using the Non-Motor Symptoms Scale (NMSS)

  Alexander Storch;Alexander Storch;Alexander Storch;Christine B. Schneider;Lisa Klingelhöfer;Per Odin

  89
  Citations

• Autonomic dysfunctions in idiopathic Parkinson's disease

  Unknown

  88
  Citations

• Treatment of drooling in Parkinson's disease with botulinum toxin

  Unknown

  88
  Citations